Clinical Trials Directory

Trials / Completed

CompletedNCT06556355

Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal Therapy

Impact of Preoperative Radiation Dose to the Cervical Esophagus on Anastomotic Leak in Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Chemoradiation and McKeown Esophagectomy: A Retrospective Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
218 (actual)
Sponsor
Qiaoqiao Li · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To investigate the clinical factors and preoperative treatment to the future anastomotic location of cervical esophagus that were correlated with anastomotic leaks in esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoradiation and McKeown esophagectomy and to explore the prognosis of anastomotic leak.

Detailed description

The goal of this observational study is to investigate the clinical factors and preoperative treatment to the future anastomotic location of cervical esophagus that were correlated with anastomotic leaks in esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoradiation and McKeown esophagectomy and to explore the postoperative complications, mortality, and long-term survival of different types of anastomotic leak.

Conditions

Interventions

TypeNameDescription
OTHERneoadjuvant chemoradiation and McKeown esophagectomyTreatment protocol: 1. All patients were irradiated a total prescribed dose of 40-50.4 Gy in 20-28 fractions by a 6-8 MV photons linear accelerator with the intensity-modulated radiotherapy or volumetric modulated arc therapy technique. 2. Concurrent chemotherapy was cisplatin-based. 3. McKeown esophagectomy (three incision) consisted of thoracic esophageal mobilization with lymphadenectomy, abdominal exploration and stomach mobilization with lymphadenectomy, and subsequently left cervical incision for anastomosis. The lymphadenectomy was total two-field (thoracic + abdomen).

Timeline

Start date
2022-11-01
Primary completion
2023-09-15
Completion
2023-09-15
First posted
2024-08-16
Last updated
2024-08-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06556355. Inclusion in this directory is not an endorsement.